Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Mann

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Plos One|June 23, 2009
Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccineJulia Romanova, Brigitte M Krenn, Markus Wolschek, et al.
Plos Pathogens|July 14, 2020
Minimal transmission in an influenza A (H3N2) human challenge-transmission model within a controlled exposure environmentJonathan S Nguyen-Van-Tam, Ben Killingley, Joanne Enstone, et al.
Clinical Pharmacology and Therapeutics|March 22, 2020
Treatment of Fabry's Disease With Migalastat: Outcome From a Prospective Observational Multicenter Study (FAMOUS)Malte Lenders, Peter Nordbeck, Christine Kurschat, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 5, 2022
Treatment of Fabry Disease management with migalastat-outcome from a prospective 24 months observational multicenter study (FAMOUS)Malte Lenders, Peter Nordbeck, Christine Kurschat, et al.
Nature Communications|November 25, 2025
Ancient gene clusters govern the initiation of monoterpenoid indole alkaloid biosynthesis and C3 stereochemistry inversionJaewook Hwang, Jonathan Kirshner, Daniel André Ramey Deschênes, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Plos One|June 23, 2009
Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccineJulia Romanova, Brigitte M Krenn, Markus Wolschek, et al.
Plos Pathogens|July 14, 2020
Minimal transmission in an influenza A (H3N2) human challenge-transmission model within a controlled exposure environmentJonathan S Nguyen-Van-Tam, Ben Killingley, Joanne Enstone, et al.
Clinical Pharmacology and Therapeutics|March 22, 2020
Treatment of Fabry's Disease With Migalastat: Outcome From a Prospective Observational Multicenter Study (FAMOUS)Malte Lenders, Peter Nordbeck, Christine Kurschat, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 5, 2022
Treatment of Fabry Disease management with migalastat-outcome from a prospective 24 months observational multicenter study (FAMOUS)Malte Lenders, Peter Nordbeck, Christine Kurschat, et al.
Nature Communications|November 25, 2025
Ancient gene clusters govern the initiation of monoterpenoid indole alkaloid biosynthesis and C3 stereochemistry inversionJaewook Hwang, Jonathan Kirshner, Daniel André Ramey Deschênes, et al.
Pageof 4